ArticlePolymers2023
Assembly of Supramolecular Nanoplatelets with Tailorable Geometrical Shapes and Dimensions.
Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 6 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
The craving for controllable assembly of geometrical nanostructures from artificial building motifs, which is routinely achieved in naturally occurring systems, has been a perpetual and outstanding challenge in the field of chemistry and materials science. In particular, the assembly of nanostructures with different geometries and controllable dimensions is crucial for their functionalities and is usually achieved with distinct assembling subunits via convoluted assembly strategies. Herein, we report that with the same building subunits of α-cyclodextrin (α-CD)/block copolymer inclusion complex (IC), geometrical nanoplatelets with hexagonal, square, and circular shapes could be produced by simply controlling the solvent conditions via one-step assembly procedure, driven by the crystallization of IC. Interestingly, these nanoplatelets with different shapes shared the same crystalline lattice and could therefore be interconverted to each other by merely tuning the solvent compositions. Moreover, the dimensions of these platelets could be decently controlled by tuning the overall concentrations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.